Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06689800 · ClinicalTrials.gov registry record · NA

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

A NA study of Sickle Cell Disease and Solid Tumor, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06689800: Recruiting NA study of Sickle Cell Disease and Solid Tumor, sponsored by Washington University School of Medicine.

NCT06689800 is a NA study of Sickle Cell Disease and Solid Tumor that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 60 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06689800, a NA study of Sickle Cell Disease and Solid Tumor, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).

Primary Outcome

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Conditions Studied

Sickle Cell Disease Solid Tumor Hematologic Malignancy Aplastic Anemia Immune Deficiency Metabolic Disorder

Interventions

  • BEHAVIORAL Let's Get REAL

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-11-26
Est. Completion 2026-05-31
Phase NA
Washington University School of Medicine

1,502 total trials

What NCT06689800 shows while recruiting

NCT06689800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (80% lower).

The record links to 6 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Let's Get REAL is the first listed.

NCT06689800 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT06689800 about?

NCT06689800 is a clinical study titled "Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy". The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention ...

What is the current status of trial NCT06689800?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-11-26. Estimated completion is 2026-05-31.

What conditions does trial NCT06689800 study?

This clinical trial studies the following conditions: Sickle Cell Disease, Solid Tumor, Hematologic Malignancy, Aplastic Anemia, Immune Deficiency.

What interventions are being tested in trial NCT06689800?

The interventions under investigation include: Let's Get REAL (BEHAVIORAL).

Who is sponsoring clinical trial NCT06689800?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06689800 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06689800's enrollment target sits among peer trials

60 93rd of 213 higher than 118 of 213 other Sickle Cell Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06689800

Source: ClinicalTrials.gov NCT06689800, the US trial registry maintained by the National Library of Medicine. NCT06689800 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.